Searchable abstracts of presentations at key conferences in endocrinology

ea0022p115 | Bone/Calcium | ECE2010

Extraosseous effects of raloxifene in osteoporotic postmenopausal women

Sebastian-Ochoa Arantzazu , Fernandez-Garcia Diego , Reyes Garcia Rebeca , Munoz Torres Manuel

Raloxifene is a selective estrogen receptor modulator which has shown to decrease bone resorption, increase bone density and reduce vertebral fracture rate in women with postmenopausal osteoporosis. Recent studies have shown a decrease on breast cancer incidence after raloxifene treatment. Although the mechanism is not clear, its mixed agonist and antagonist properties in different tissues could partially explain this effect.Objective: To evaluate the ef...

ea0020p247 | Bone/Calcium | ECE2009

Changes in adipokines serum levels after anticatabolic drugs in postmenopausal osteoporosis

Sebastian-Ochoa Arantzazu , Fernandez-Garcia Diego , Reyes-Garcia Rebeca , Munoz-Torres Manuel

Adiponectin and leptin have been described as potential contributors to bone metabolism. The effect of anticatabolic drugs on these adipokines and their relationship with bone metabolism have not been clearly clarified.Aims: (1) Evaluate adiponectin and leptin levels in osteoporosic postmenopausal women and their relationship with BMD, bone turnover and osteoclastogenesis markers. (2) Analyze changes on adiponectin and leptin levels after treatment with ...

ea0020p253 | Bone/Calcium | ECE2009

Vitamin D inadequacy in patientes who are screened for osteoporosis

Reyes-Garcia Rebeca , Fernandez-Garcia Diego , Sebastian-Ochoa Arantzazu , Munoz-Torres Manuel

Low concentrations of vitamin D leads to secondary hiperparathyroidism, bone loss, and an increase of osteoporotic fractures in populations at risk. Adequate vitamin D and calcium intake is considered an essential component of postmenopausal osteoporosis management. Several epidemiological studies have assessed the prevalence of low serum vitamin D concentrations, indicating that vitamin D inadequacy (<30 ng/ml) is a problem world-wide.Aims: To evalu...

ea0035p91 | Bone and Osteoporosis | ECE2014

Usefulness of serum sclerostin as a diagnostic marker of osteoporosis in a cohort of spanish postmenopausal women

Luque-Fernandez Ines , Garcia-Martin Antonia , Reyes-Garcia Rebeca , Morales-Santana Sonia , Garcia-Fontana Beatriz , Munoz-Torres Manuel

Introduction: Sclerostin, produced by osteocytes, is a potent inhibitor of Wnt signaling and bone formation. The usefulness of its determination in clinical practice is not well established.Objectives: The aims of this study were to evaluate serum sclerostin levels in a cohort of Spanish posmenopausal women, and to analyze its relationship with bone metabolism.Methods: We measured serum sclerostin in 97 posmenopausal women using EL...

ea0032p595 | Female reproduction | ECE2013

Association of serum 25-hydroxyvitamin D and glucose levels in polycystic ovary syndrome

Lopez-Gallardo Gema , Rozas-Moreno Pedro , Reyes-Garcia Rebeca , Tenias-Burillo Jose Maria , Lopez-Iglesias Maria , Garcia-Manzanares Alvaro , Gomez Francisco-Javier , Gomez-Garcia Ines

Background: Women with polycystic ovary syndrome (PCOS) frequently suffer from metabolic disturbances, in particular from pre-diabetes and diabetes. Conflicting results currently exists on the relationship between vitamin D and glucose metabolism. Hence, the aim of our study was to investigate the association of 25-hydroxyvitamin D (25(OH)D) levels and glucose tolerance in PCOS women.Methods: Cross-sectional study including 23 PCOS patients (mean age 27 ...

ea0070aep328 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

The icone study’: Multicenter evaluation of the impact of contour next one and contour diabetes app on self-management and adherence in insulin-treated patients with diabetes type 1 or 2

Fernandez-Garcia Diego , Aguilera Hurtado Eva , Arranz Martin Alfonso , Gonzalez Aguilera Beatriz , Gonzalez Jauregui Blanca , Luis Menendez Torre Edelmiro , Reyes Garcia Rebeca , Soto Gonzalez Alfonso , Tejera Perez Cristina , Fernandez-Tresguerres Beatriz , Petruschke Thorsten

Objectives: The primary objective was to determine if the use of Contour Next One (CNO) with Contour Diabetes app (APP) was associated with improved self-management using the Summary of Diabetes Self-Care Activities questionnaire (SDSCA). A secondary objective was to establish if CNO and APP together had impact on adherence to self-monitoring blood glucose (BG), indicated by frequency of BG readings and hypoglycemic events. Other secondary objectives were to observe a possible...